FINE PARTICLE SIZE PIOGLITAZONE

Details for Australian Patent Application No. 2003230719 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors SAMBURSKI, Guy; DOLITZKY, BenZion

Pub. Number AU-A-2003230719

PCT Number PCT/US03/08945

PCT Pub. Number WO2003/080056

Priority 60/366,352 21.03.02 US

Filing date 21 March 2003

Wipo publication date 8 October 2003

International Classifications

A61K 031/4439

A61K 009/14 Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/366,352 21.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-A-2003230719

13 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003230720-DIHYDROBENZOFURAN AND DIHYDROBENZOTHIOPHENE 2,4-PENTAIDENOIC ACID DERIVATIVES HAVING SELECTIVE ACTIVITY FOR RETINOID X (RXR) RECEPTORS

2003230718-Treatment of diseases involving defective gap junctional communication